Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells.

Silva PBG, Teixeira Dos Santos MC, Rodini CO, Kaid C, Leite Pereira MC, Furukawa G, Gimenes da Cruz DS, Goldfeder MB, Reily Rocha CR, Rosenberg C, Okamoto OK.

Oncotarget. 2017 Feb 7. doi: 10.18632/oncotarget.15163. [Epub ahead of print]

2.

Genetic analyses of Per.C6 cell clones producing a therapeutic monoclonal antibody regarding productivity and long-term stability.

Tsuruta LR, Lopes Dos Santos M, Yeda FP, Okamoto OK, Moro AM.

Appl Microbiol Biotechnol. 2016 Dec;100(23):10031-10041.

PMID:
27678118
3.

Establishment of a novel human medulloblastoma cell line characterized by highly aggressive stem-like cells.

Silva PB, Rodini CO, Kaid C, Nakahata AM, Pereira MC, Matushita H, Costa SS, Okamoto OK.

Cytotechnology. 2016 Aug;68(4):1545-60. doi: 10.1007/s10616-015-9914-5.

PMID:
26358937
4.

miR-367 promotes proliferation and stem-like traits in medulloblastoma cells.

Kaid C, Silva PB, Cortez BA, Rodini CO, Semedo-Kuriki P, Okamoto OK.

Cancer Sci. 2015 Sep;106(9):1188-95. doi: 10.1111/cas.12733.

5.

Embryonic Stem Cell-Related Protein L1TD1 Is Required for Cell Viability, Neurosphere Formation, and Chemoresistance in Medulloblastoma.

Santos MC, Silva PB, Rodini CO, Furukawa G, Marco Antonio DS, Zanotto-Filho A, Moreira JC, Okamoto OK.

Stem Cells Dev. 2015 Nov 15;24(22):2700-8. doi: 10.1089/scd.2015.0052.

PMID:
26159230
6.

Stem Cells in Translational Cancer Research.

Okamoto OK, Matheu A, Magnani L.

Stem Cells Int. 2015;2015:281072. doi: 10.1155/2015/281072. No abstract available.

7.

Combined effects of pericytes in the tumor microenvironment.

Ribeiro AL, Okamoto OK.

Stem Cells Int. 2015;2015:868475. doi: 10.1155/2015/868475. Review.

8.

Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200.

Lindegren S, Andrade LN, Bäck T, Machado CM, Horta BB, Buchpiguel C, Moro AM, Okamoto OK, Jacobsson L, Cederkrantz E, Washiyama K, Aneheim E, Palm S, Jensen H, Tuma MC, Chammas R, Hultborn R, Albertsson P.

PLoS One. 2015 May 13;10(5):e0126298. doi: 10.1371/journal.pone.0126298.

9.

Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?

Coatti GC, Beccari MS, Olávio TR, Mitne-Neto M, Okamoto OK, Zatz M.

Cytometry A. 2015 Mar;87(3):197-211. doi: 10.1002/cyto.a.22630. Review.

10.

Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR.

Valente V, Teixeira SA, Neder L, Okamoto OK, Oba-Shinjo SM, Marie SK, Scrideli CA, Paçó-Larson ML, Carlotti CG Jr.

Ann Neurosci. 2014 Apr;21(2):62-3. doi: 10.5214/ans.0972.7531.210207. No abstract available.

11.

RNAi-mediated knockdown of E2F2 inhibits tumorigenicity of human glioblastoma cells.

Nakahata AM, Suzuki DE, Rodini CO, Fiuza ML, Okamoto OK.

Oncol Lett. 2014 Oct;8(4):1487-1491.

12.

Knockdown of E2F2 inhibits tumorigenicity, but preserves stemness of human embryonic stem cells.

Suzuki DE, Nakahata AM, Okamoto OK.

Stem Cells Dev. 2014 Jun 1;23(11):1266-74. doi: 10.1089/scd.2013.0592.

PMID:
24446828
13.

Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer.

Lopes dos Santos M, Yeda FP, Tsuruta LR, Horta BB, Pimenta AA Jr, Degaki TL, Soares IC, Tuma MC, Okamoto OK, Alves VA, Old LJ, Ritter G, Moro AM.

PLoS One. 2013 Jul 31;8(7):e70332. doi: 10.1371/journal.pone.0070332.

14.

The role of DNA repair in the pluripotency and differentiation of human stem cells.

Rocha CR, Lerner LK, Okamoto OK, Marchetto MC, Menck CF.

Mutat Res. 2013 Jan-Mar;752(1):25-35. doi: 10.1016/j.mrrev.2012.09.001. Review.

PMID:
23010441
15.

Systemic delivery of human mesenchymal stromal cells combined with IGF-1 enhances muscle functional recovery in LAMA2 dy/2j dystrophic mice.

Secco M, Bueno C Jr, Vieira NM, Almeida C, Pelatti M, Zucconi E, Bartolini P, Vainzof M, Miyabara EH, Okamoto OK, Zatz M.

Stem Cell Rev. 2013 Feb;9(1):93-109. doi: 10.1007/s12015-012-9380-9.

PMID:
22664740
16.

In silico analysis and immunohistochemical characterization of NaPi2b protein expression in ovarian carcinoma with monoclonal antibody Mx35.

Soares IC, Simões K, de Souza JE, Okamoto OK, Wakamatsu A, Tuma M, Ritter G, Alves VA.

Appl Immunohistochem Mol Morphol. 2012 Mar;20(2):165-72.

PMID:
22553815
17.

Homeobox gene expression profile indicates HOXA5 as a candidate prognostic marker in oral squamous cell carcinoma.

Rodini CO, Xavier FC, Paiva KB, De Souza Setúbal Destro MF, Moyses RA, Michaluarte P, Carvalho MB, Fukuyama EE; Head And Neck Genome Project Gencapo., Tajara EH, Okamoto OK, Nunes FD.

Int J Oncol. 2012 Apr;40(4):1180-8. doi: 10.3892/ijo.2011.1321.

18.

Autophagy in stem cell maintenance and differentiation.

Vessoni AT, Muotri AR, Okamoto OK.

Stem Cells Dev. 2012 Mar 1;21(4):513-20. doi: 10.1089/scd.2011.0526. Review.

PMID:
22066548
19.

Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma.

Rodini CO, Suzuki DE, Saba-Silva N, Cappellano A, de Souza JE, Cavalheiro S, Toledo SR, Okamoto OK.

J Neurooncol. 2012 Jan;106(1):71-9. doi: 10.1007/s11060-011-0647-9.

PMID:
21725800
20.

Insights on PRAME and osteosarcoma by means of gene expression profiling.

Toledo SR, Zago MA, Oliveira ID, Proto-Siqueira R, Okamoto OK, Severino P, Vêncio RZ, Gamba FT, Silva WA, Moreira-Filho CA, Torre CA, Alves MT, Garcia-Filho RJ, Simpson AJ, Petrilli AS.

J Orthop Sci. 2011 Jul;16(4):458-66. doi: 10.1007/s00776-011-0106-7.

PMID:
21691740
Items per page

Supplemental Content

Loading ...
Support Center